Home
Integrated Core Strategies reported a 6.3% stake in AN2 Therapeutics ANTX · 2,237,102 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 6.3%
- Last report
- First report
- Shares held
- 2,237,102 sh
- Class
- Common Stock, par value $0.00001 per share
- Event date
- 26/03/06
- Filed
- 26/03/13
First 5%+ report · 6.3% stake
AN2 Therapeutics trades, last 26 weeks
What else happened in AN2 Therapeutics around then
Filed or reported within 30 days of the trade day · 02/04~04/05Integrated Core Strategies's other 5% stake reports
- Integrated Core Strategies
5% stakeBetter Home & Finance Holding
5% stakeBetter Home & Finance Holding
BETR
5.5% stake
730,265 sh
5.5% stake
Filed 09/22
- Integrated Core Strategies
5% stakeKaryopharm Therapeutics
5% stakeKaryopharm Therapeutics
KPTI
5.7% stake
1,297,297 sh
5.7% stake
Filed 09/04
- Integrated Core Strategies
5% stakeFortress Biotech
5% stakeFortress Biotech
FBIO
5.3% stake
1,778,561 sh
5.3% stake
Filed 09/01
- Integrated Core Strategies
5% stakeTenaya Therapeutics
5% stakeTenaya Therapeutics
TNYA
5.2% stake
11,581,565 sh
5.2% stake
Filed 08/24
- Integrated Core Strategies
5% stakeCollegium Pharmaceutical
5% stakeCollegium Pharmaceutical
COLL
5.6% stake
1,820,330 sh
5.6% stake
Filed 08/24
